Edmond de Rothschild completed the acquisition of a majority stake in Aiglon.

Edmond de Rothschild, a private equity firm, completed the acquisition of a majority stake in Aiglon, a group specializing in the design and manufacture of pharmaceutical and cosmetic ingredients. Financial terms were not disclosed. "This transmission operation is fully in line with the strategy of the EDRPE Trajan 2 fund to ensure the sustainability of successful family SMEs, creators of jobs, connectivity and regional prosperity," Johnny El Hachem, Edmond de Rothschild Private Equity CEO.